2006, Number 2
<< Back Next >>
Med Cutan Iber Lat Am 2006; 34 (2)
Potassium iodide in the treatment of recurrent staphylococcal skin infections
Vignalea RA, Paciel VJ
Language: Spanish
References: 20
Page: 57-62
PDF size: 386.98 Kb.
ABSTRACT
An open clinical study was performed to know the therapeutic value of the potassium iodide administered in saturated solution form (SSKI) for the treatment of recurrent staphylococcal skin infections. The included cases presented three clinical forms of the infection: 16 cases of folliculitis, 10 cases with furuncles and 4 cases with carbuncle. To be included the patients they should behave an affection of three or more years of evolution and to have six or more annual relapses in those a treatment with systemic antibiotic should be used. The SSKI was administered to a concentration of 47 mg/drop during 12 months to an initial dose of 1.41 g/day, increasing 0,705 mg every 6-7 days until a daily dose of 4.23 g/day. In the first consultation it was also used a treatment with systemic and topic antibiotics. The relapses disappeared and the therapy with systemic antibiotics were not necessary after the second month of treatment. Relapses of the infection were not observed in the following months as neither after 12 months after having concluded the treatment. Adverse reactions were not observed by the employment of SSKI during the two years of follow-up. It is considered that the SSKI is useful for the treatment of recurrent staphylococcal skin infections. The SSKI does not create bacterial resistance and it preserves the employment of antibiotics for other more serious infections.
REFERENCES
1 Sterling JB, Heymann WR. Protassium iodide in dermatology: a 19th century drug for de 21st century – Uses, pharmacology, adverse effects and contraindications. J Am Acad Dernatol 2000:43;691-7.
2 Dollery C (Ed) Therapeutis Drugs. CD-Rom Database Version 1.0. Harcourt Brace and Company Limited. Filadelfia, 1999. www.harcourt.com
3 Cairo N. Guia de Medicina Homeopática. Libraría Teixeira. Ferreira Girào & Cia.Ltda.. San Pablo, 1961.
4 Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine, and dapsone on the generation of polymorphonuclear leukocyte-derived oxigen intermediates. Br J Dermatol 1982:107;209-14.
5 Honna K, Saga K, Ondera H, Takahashi M. Potassium Iodide inhibits neutrophil chemotaxis. Acta Derm Venéreol 1990:70;247-9.
6 Negro RC., Gentile IG., Mackinon JE., Osimani JJ., Gajer M., Paciel J. et al. Enfermedades infecciosas. 2ª edición. Tomo I. Librería Médica Editorial. Montevideo, 1988. Pág.27-60.
7 Hirschmann JV, Feingold DS. Staphylococcal and Streptococcal skin or soft tissue infections. En: SL Gorbach, JG Bartlett, MR Blacklow. Infectious diseases. WB Saunders Company. Filadelfia. 1992. Pág.1069-1071.
8 Souillet G, Germain D, Carraz M, Veyssere C, Frobet Y. La bactericidie des polynucléarires neutrophiles. Nouv Rev Fr Hemat 1974;14:257-73.
9 Vignale R, Lasalvia E, Paciel J. La prueba del nitroazul de tetrazolio en al acne vulgar. Med Cutan Iber Lat Am 1977;4:275.
10 Vignale R, Lasalvia E, Paciel J. Función del granulocito neutrófilo en el acné vulgar. Med Cutan Iber Lat Am 1988;16:351-4.
11 Lasalvia E, Paciel J, Tarallo N, Kierszenblat F, Villagra J, Oehninger C. Insuficiencia de la fagocitosis granulocitaria en la enfermedad pulmonar obstructiva crónica. El Tórax 1974:23:175.
12 Vignale R, Lasalvia E, Paciel J, Gibert P. Función del granulocito neutrófilo en al acne vulgar en pacientes tratados con isotretinoina (13 cis-retinoide). Rev Arg Derm 1988;69:155.
13 Tio T, de Vries G. Subcutaneous zygomycosis (phycomycosis) S Afr Med J 1977;52:77-8.
14 Klebanoff SJ. Intraleukocytic microbicidal defects. Ann Rev Med 1971;22:39.
15 McRipley RJ, Sbarra KG. Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide myeloperoxidase bactericidal system in the phagocyte- J Bact 1967:94:1425.
16 Klebanoff SJ. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacter 1968;85:2131.
17 Klebanoff SJ. Iodination of bacteria: a bacterial mechanism. J Exp Med 1967;126:1063.
18 Hiruma M, Kagawa S. Ultraestructure of Sporothrix shenckii treated with iodine-potassium iodide solution. Mycopathologia 1987;91:121-7.
19 Jacobs AA, Mitchel GWJr, Strauss RR, Paul BB, Sbarra AJ. The role of the phagocyte in host parasite interactions. XXXV. Serum and cellular iodine levels and their relationships to the hyperbactericidal activity of pregnancy. Amer J Obs Ginecol 1971;110:911.
20 Rex J, Bennett J. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix shenckii by they neutrophils or monocytes. J Med Vet Mycol 1990;28:185-9.